Abstract Three-dimensional (3D) extrusion-based bioprinting is widely used in tissue
engineering and regenerative medicine to create cell-incorporated constructs or scaffolds …

When blood first encounters the artificial surface of a medical device, a complex series of
biochemical reactions is triggered, potentially resulting in clinical complications such as …

Cardiovascular defects, injuries, and degenerative diseases often require surgical
intervention and the use of implantable replacement material and conduits. Traditional …

Biomaterials play a critical role in engineering of tissue constructs, working as an artificial
extracellular matrix to support regeneration. Because the elastic stretchability is a major …

Almost 30 years have passed since a term 'tissue engineering'was created to represent a
new concept that focuses on regeneration of neotissues from cells with the support of …

Advances in standards of care have extended the life expectancy of patients with kidney
failure. However, options for chronic vascular access for haemodialysis—an essential part of …

Traditional vascular grafts constructed from synthetic polymers or cadaveric human or
animal tissues support the clinical need for readily available blood vessels, but often come …

The aim of this study was to build a mechanically enhanced three-dimensional (3D)
bioprinted construct containing two different cell types for osteochondral tissue regeneration …

There is a persistent and growing clinical need for readily-available substitutes for heart
valves and small-diameter blood vessels. In situ tissue engineering is emerging as a …

Biodegradable scaffolds seeded with bone marrow mononuclear cells (BMCs) are the
earliest tissue-engineered vascular grafts (TEVGs) to be used clinically. These TEVGs …